nu

Philips still plagued by sleep apnea scandal: CEO also sued

Philips still plagued by sleep apnea scandal: CEO also sued

Philips continues to face legal repercussions from its 2021 sleep apnea device recall, with American investors filing a lawsuit against CEO Roy Jakobs in December. Investors in the Netherlands are also pursuing claims to hold the company liable for the ongoing crisis.

Based on reporting by nu. Translated and condensed by LocalHeadlines.

Related articles

The insane week at Albert Heijn: ‘We grabbed things at random and sent them to stores’

The insane week at Albert Heijn: ‘We grabbed things at random and sent them to stores’

Dutch supermarket chain Albert Heijn recently experienced a significant cyber incident that forced them to take many internal systems offline. The disruption impacted both warehouse operations and retail staff, who faced logistical challenges and increased stress while managing store supplies without standard digital tools.

Vacancy | NU.nl is looking for a social economy and healthcare reporter

Vacancy | NU.nl is looking for a social economy and healthcare reporter

NU.nl is hiring a reporter specializing in social economy and healthcare to produce original, investigative stories for its audience. The full-time position requires three years of experience and is based in Amsterdam-Duivendrecht.

Albert Heijn online grocery delivery unavailable until at least Tuesday, customer data appears safe for now

Albert Heijn online grocery delivery unavailable until at least Tuesday, customer data appears safe for now

Albert Heijn has suspended all online grocery deliveries until at least Tuesday due to a cyber incident that also took down its websites and apps. While the supermarket reports no evidence of data theft, authorities are urging the company to file an official police report to support the ongoing investigation.

Criminals steal huge quantity of insulin pens from Novo Nordisk

Criminals steal huge quantity of insulin pens from Novo Nordisk

Novo Nordisk has reported the theft of a large quantity of insulin pens from a medical wholesaler, raising concerns about their illegal sale. The manufacturer warns that these stolen items could be falsely marketed as weight-loss drugs, posing life-threatening risks to non-diabetic users who might accidentally inject insulin.

Apax becomes sole owner of Odido in multi-billion deal

Apax becomes sole owner of Odido in multi-billion deal

Private equity firm Apax Partners is acquiring full ownership of the Dutch telecommunications company Odido in a deal reportedly valued at 6.5 billion euros. The transaction is pending regulatory approval and follows the firm's previous joint purchase of the company in 2021.